Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31944221

Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2020 Mar 1
First author
Shen S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2020 Mar 1;6(3):333-334. doi: 10.1001/jamaoncol.2019.5849.
    note
    Source null
    related pmid
    31944218
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Feb;21(2):e73. doi: 10.1016/S1470-2045(20)30031-0.
    note
    Source null
    related pmid
    31982033
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2020 Apr;17(4):197. doi: 10.1038/s41571-020-0337-7.
    note
    Source null
    related pmid
    31996797
    relationship
    Comment in

Authors and identifiers

  1. name
    Shen S
    type
    Author
  2. name
    Chen X
    type
    Author
  3. name
    Cai J
    type
    Author
  4. name
    Yu J
    type
    Author
  5. name
    Gao J
    type
    Author
  6. name
    Hu S
    type
    Author
  7. name
    Zhai X
    type
    Author
  8. name
    Liang C
    type
    Author
  9. name
    Ju X
    type
    Author
  10. name
    Jiang H
    type
    Author
  11. name
    Jin R
    type
    Author
  12. name
    Wu X
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shen S
    type
    Author
  2. name
    Chen X
    type
    Author
  3. name
    Cai J
    type
    Author
  4. name
    Yu J
    type
    Author
  5. name
    Gao J
    type
    Author
  6. name
    Hu S
    type
    Author
  7. name
    Zhai X
    type
    Author
  8. name
    Liang C
    type
    Author
  9. name
    Ju X
    type
    Author
  10. name
    Jiang H
    type
    Author
  11. name
    Jin R
    type
    Author
  12. name
    Wu X
    type
    Author
bibliography ids
  1. nci-bib-085683a1046253511c6b5e91
book metadata
content sha256
51c0359d46df6ddd39e7c5edb087faa2404cddb7526e48549c216457e8d37b39
document type
citation
dois
  1. 10.1001/jamaoncol.2019.5868
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31944221
immutable id
pubmed:31944221@51c0359d46df6ddd39e7c5edb087faa2404cddb7526e48549c216457e8d37b39
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
3
name
JAMA oncology
nlm unique id
101652861
pages
358-366
volume
6
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2020 Mar 1;6(3):333-334. doi: 10.1001/jamaoncol.2019.5849.
    note
    Source null
    related pmid
    31944218
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Feb;21(2):e73. doi: 10.1016/S1470-2045(20)30031-0.
    note
    Source null
    related pmid
    31982033
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2020 Apr;17(4):197. doi: 10.1038/s41571-020-0337-7.
    note
    Source null
    related pmid
    31996797
    relationship
    Comment in
outcomes validated
false
pmid
31944221
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
6ccfd292f51e9f5e3dd6c158fae310fe7594e4470e25c4027a6223dbdbecd7cb
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Mar 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31944221/
title
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Preserved source evidence · Not medical advice